Position in ZYME
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$5,179,624
+$3,117,038 QoQ
Shares Held
206,854
+164.1% QoQ
Ownership
0.283%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
6 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in ZYME Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PANAGORA ASSET MANAGEMENT INC holds $504,243,073 across 65 Biotechnology names. ZYME ranks #18 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
1,210,909 | $113,970,755 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
105,225 | $81,301,044 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
742,117 | $55,109,608 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
461,193 | $28,916,801 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
143,499 | $27,128,485 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
351,370 | $23,938,838 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
592,912 | $17,615,415 | |
| 8 | ONC |
BeOne Medicines Ltd.
|
57,320 | $17,022,320 |
All Filings in ZYME
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,179,624 | 206,854 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,062,586 | 78,336 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,811,709 | 106,072 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $421,165 | 33,559 | Shares | Sole | 2025-08-13 | |
| 2024-12-31 | $3,137,908 | 214,338 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,265,868 | 100,866 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||